Roth Capital Upgrades Spectrum Pharmaceuticals (SPPI) to Buy
Tweet
Share
E-mailGet Alerts SPPI Hot Sheet
Price: $1.03 --0%
Rating Summary:
3 Buy, 6 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Rating Summary:
3 Buy, 6 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Join SI Premium – FREE
Roth Capital upgraded Spectrum Pharmaceuticals (NASDAQ: SPPI) from Neutral to Buy, price target raised from $11 to $20.
For an analyst ratings summary and ratings history on Spectrum Pharmaceuticals click here. For more ratings news on Spectrum Pharmaceuticals click here.
Shares of Spectrum Pharmaceuticals closed at $14.99 yesterday.
For an analyst ratings summary and ratings history on Spectrum Pharmaceuticals click here. For more ratings news on Spectrum Pharmaceuticals click here.
Shares of Spectrum Pharmaceuticals closed at $14.99 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA Securities Upgrades Bharat Forge Ltd. (BHFC:IN) to Buy
- BofA Securities Upgrades Tesla (TSLA) to Buy on wind up of positive catalysts
- Wells Fargo Upgrades Neurocrine Bio. (NBIX) to Overweight 'as the Company is Knocking on the Doors of the Large-Cap Club'
Create E-mail Alert Related Categories
UpgradesRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
